Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes
Brian E. McGarry, Benjamin D. Sommers, Andrew D. Wilcock, David C. Grabowski, Michael L. Barnett
Abstract
This study examines the use of COVID-19 antiviral treatments in US nursing homes and the facility characteristics associated with use of oral antivirals and monoclonal antibodies.
Topics & Concepts
MedicineMonoclonal antibodyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyNursing homesMonoclonalAntibodyImmunologyIntensive care medicineInternal medicineNursingOutbreakInfectious disease (medical specialty)DiseaseCOVID-19 and healthcare impactsInfection Control and VentilationLong-Term Effects of COVID-19